Clinical Trials Browser

Phase 1 × Advanced Malignancies × parsaclisib × Clear all

NCT04831944 2022-08-26

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

Phase 1 Completed

Advanced Malignancies

NCT04831996 2022-08-17

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Renal Function and Renal Impairment.

Phase 1 Completed

Advanced Malignancies